Instead of titrating to the full doses recommended for obesity treatment (e.g., semaglutide 2.4 mg weekly or tirzepatide up to 15 mg), microdosing involves starting and staying at much lower doses sometimes as low as 0.1 to 0.25 mg per week for semaglutide or even intermittent use
CrossRef Human stem cell-derived hepatic cells recapitulate polygenic risk in MASLD development and highlight CD36 as a key mediator Alexandra Gatzios, Marth Stinckens, Anouk Verhoeven, Matthias Rombaut, Dinja De Win, Anja Heymans, Arne Loosen, Freddy Van Goethem, Joery De Kock, Robim M
Later studies should sample blood sugars more frequently to determine if the blood sugars and BrAC effects mirror each other
Low-level glucagon receptor engagement nudges the body to oxidise fat and may raise resting energy expenditure modestly
trial approval for HDM1002, an oral GLP-1 full agonist, demonstrating Chinas expanding international research collaborations and technological strength